Abstract
Gold nanoparticles (GNPs) are promising platforms for combining imaging and therapeutic functions, but assessing the functional accessibility of ligands remains essential for their development. Herein, we developed a tunable biointerface on a Surface Plasmon Resonance (SPR) chip to screen the interactions of mannose-functionalized gold nanoparticles (GNP-Man) with Concanavalin A (ConA), used as a “mannose-binding lectin” model. The biointerface is based on a supramolecular architecture of a self-assembled monolayer (SAM) of TADOTAGA formed on a bare gold chip, followed by a covalent grafting of mannose and the immobilization of ConA in a controlled manner. The resulting surface showed reproducible preparation, good stability, and efficient regeneration. Five GNP-Man batches with nominal Man/GNP ratios of 10, 20, 50, 100 and 200 were characterized by TEM, DLS, and UV–visible spectroscopy. A dose–response study with GNP-Man10 validated the SPR methodology, followed by a comparative screening of all formulations at 30 µg/mL. SPR responses increased with the nominal mannose density, whereas non-functionalized GNPs showed only a limited response. This proof of concept demonstrates the potential of a reusable SPR biointerface for comparative screening of GNP-Man formulations based on their functional recognition by lectins, providing a first step toward the biophysical evaluation of C-type lectin receptor (CLR)-targeted nanovectors.